Severe rhabdomyolysis associated with pemetrexed-based chemotherapy

Anna Ceribelli; Fabiana Letizia Cecere; Michele Milella; Francesco Facciolo; Alain Gelibter; Francesco Cognetti

doi:10.1016/S1470-2045(06)70662-3

Severe rhabdomyolysis associated with pemetrexed-based chemotherapy

Anna Ceribelli, Fabiana Letizia Cecere, Michele Milella, Francesco Facciolo, Alain Gelibter, Francesco Cognetti

Istituto Regina Elena

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	353
Number of pages	1
Journal	The Lancet Oncology
Volume	7
Issue number	4
DOIs	https://doi.org/10.1016/S1470-2045(06)70662-3
Publication status	Published - Apr 2006

ASJC Scopus subject areas

Oncology

Access to Document

10.1016/S1470-2045(06)70662-3

Cite this

Ceribelli, A., Cecere, F. L., Milella, M., Facciolo, F., Gelibter, A., & Cognetti, F. (2006). Severe rhabdomyolysis associated with pemetrexed-based chemotherapy. The Lancet Oncology, 7(4), 353. https://doi.org/10.1016/S1470-2045(06)70662-3

@article{ecf7c2a3532341b0b643175fbba42268,

title = "Severe rhabdomyolysis associated with pemetrexed-based chemotherapy",

author = "Anna Ceribelli and Cecere, {Fabiana Letizia} and Michele Milella and Francesco Facciolo and Alain Gelibter and Francesco Cognetti",

year = "2006",

month = apr,

doi = "10.1016/S1470-2045(06)70662-3",

language = "English",

volume = "7",

pages = "353",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "4",

}

TY - JOUR

T1 - Severe rhabdomyolysis associated with pemetrexed-based chemotherapy

AU - Ceribelli, Anna

AU - Cecere, Fabiana Letizia

AU - Milella, Michele

AU - Facciolo, Francesco

AU - Gelibter, Alain

AU - Cognetti, Francesco

PY - 2006/4

Y1 - 2006/4

UR - http://www.scopus.com/inward/record.url?scp=33645793498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645793498&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(06)70662-3

DO - 10.1016/S1470-2045(06)70662-3

M3 - Article

C2 - 16574552

AN - SCOPUS:33645793498

VL - 7

SP - 353

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 4

ER -